Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Effects of transcranial random noise stimulation (tRNS) on affect, pain and attention in multiple sclerosis.
LONGITUDINAL INTENSITY NORMALIZATION IN THE PRESENCE OF MULTIPLE SCLEROSIS LESIONS.
Correction: multiple sclerosis in the mount etna region: possible role of volcanogenic trace elements.
Use of an early disease-modifying drug adherence measure to predict future adherence in patients with multiple sclerosis.
The use of valproic acid and multiple sclerosis.
Decreased levels of repulsive guidance molecule A in association with beneficial effects of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients.
Occurrence of ecchymotic angioedema-like cutaneous lesions as a possible side effect of fingolimod.
Endogenous recovery after brain damage; molecular mechanisms that balance neuronal life/death fate.
Mutation Update of ARSA and PSAP genes causing Metachromatic Leukodystrophy.
Comparison of Intelligibility Measures for Adults with Parkinson's Disease, Multiple Sclerosis and Healthy Controls.
Subgroup analysis in MS trials.
Acute Disseminated Encephalomyelitis After Plasmodium Vivax Infection: Case Report and Review of Literature.
Oligodendrogenesis in the fornix of adult mouse brain; the effect of LPS-induced inflammatory stimulation.
Does Infection-Induced Immune Activation Contribute to Dementia?
Demyelinating disease: Neurodegeneration distinguishes MS from NMO.
Insights into the channel gating of P2X receptors from structures, dynamics and small molecules.
Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis.
Cortical lesions in multiple sclerosis: inflammation versus neurodegeneration.
[The clinical outcomes of idiopathic optic neuritis with no light perception in 21 eyes].
White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
[White matter lesions, young age, female - differential diagnosis of multiple sclerosis and juvenile stroke].
Autologous hematopoietic stem cell transplantation as a treatment option for aggressive multiple sclerosis.
Vitamin D supplementation and antibodies against the Epstein-Barr virus in multiple sclerosis patients.
Genetic factors and multiple sclerosis in the Moroccan population: A role for HLA class II.
Spinal cord lesions and disability in Hispanics with multiple sclerosis.

Pages